Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Cereb Cortex ; 28(8): 2873-2886, 2018 08 01.
Artículo en Inglés | MEDLINE | ID: mdl-29106499

RESUMEN

Neuroligin-4 (Nlgn4) is a cell adhesion protein that regulates synapse organization and function. Mutations in human NLGN4 are among the causes of autism spectrum disorders. In mouse, Nlgn4 knockout (KO) perturbs GABAergic synaptic transmission and oscillatory activity in hippocampus, and causes social interaction deficits. The complex profile of cellular and circuit changes that are caused by Nlgn4-KO is still only partly understood. Using Nlgn4-KO mice, we found that Nlgn4-KO increases the power in the alpha frequency band of spontaneous network activity in the barrel cortex under urethane anesthesia in vivo. Nlgn4-KO did not affect single-whisker-induced local field potentials, but suppressed the late evoked multiunit activity in vivo. Although Nlgn4-KO did not affect evoked EPSCs in layer 4 (L4) spiny stellate cells in acute thalamocortical slices elicited by electrical stimulation of thalamocortical inputs, it caused a lower frequency of both miniature (m) IPSCs and mEPSCs, and a decrease in the number of readily releasable vesicles at GABAergic and glutamatergic connections, weakening both excitatory and inhibitory transmission. However, Nlgn4 deficit strongly suppresses glutamatergic activity, shifting the excitation-inhibition balance to inhibition. We conclude that Nlgn4-KO does not influence the incoming whisker-mediated sensory information to the barrel cortex, but modifies intracortical information processing.


Asunto(s)
Moléculas de Adhesión Celular Neuronal/deficiencia , Potenciales Evocados/genética , Neocórtex/patología , Red Nerviosa/fisiopatología , Neuronas/fisiología , Vías Aferentes/patología , Vías Aferentes/fisiopatología , Animales , Animales Recién Nacidos , Moléculas de Adhesión Celular Neuronal/genética , Estimulación Eléctrica , Potenciales Evocados/efectos de los fármacos , Técnicas In Vitro , Ratones , Ratones Noqueados , Neocórtex/crecimiento & desarrollo , Red Nerviosa/efectos de los fármacos , Red Nerviosa/patología , Neuronas/efectos de los fármacos , Neurotransmisores/farmacología , Vibrisas/inervación , Imagen de Colorante Sensible al Voltaje
2.
J Physiol ; 592(10): 2153-68, 2014 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-24665103

RESUMEN

While the expression of glycine receptors in the immature hippocampus has been shown, no information about the role of glycine receptors in controlling the excitability in the immature CNS is available. Therefore, we examined the effect of glycinergic agonists and antagonists in the CA3 region of an intact corticohippocampal preparation of the immature (postnatal days 4-7) rat using field potential recordings. Bath application of 100 µM taurine or 10 µM glycine enhanced the occurrence of recurrent epileptiform activity induced by 20 µM 4-aminopyridine in low Mg(2+) solution. This proconvulsive effect was prevented by 3 µM strychnine or after incubation with the loop diuretic bumetanide (10 µM), suggesting that it required glycine receptors and an active NKCC1-dependent Cl(-) accumulation. Application of higher doses of taurine (≥ 1 mM) or glycine (100 µM) attenuated recurrent epileptiform discharges. The anticonvulsive effect of taurine was also observed in the presence of the GABAA receptor antagonist gabazine and was attenuated by strychnine, suggesting that it was partially mediated by glycine receptors. Bath application of the glycinergic antagonist strychnine (0.3 µM) induced epileptiform discharges. We conclude from these results that in the immature hippocampus, activation of glycine receptors can mediate both pro- and anticonvulsive effects, but that a persistent activation of glycine receptors is required to suppress epileptiform activity. In summary, our study elucidated the important role of glycine receptors in the control of neuronal excitability in the immature hippocampus.


Asunto(s)
Epilepsia/fisiopatología , Glicina/administración & dosificación , Hipocampo/fisiopatología , Receptores de Glicina/agonistas , Receptores de Glicina/metabolismo , Taurina/administración & dosificación , Animales , Animales Recién Nacidos , Anticonvulsivantes/administración & dosificación , Células Cultivadas , Epilepsia/tratamiento farmacológico , Hipocampo/efectos de los fármacos , Ratas , Ratas Wistar
3.
Epilepsy Res ; 108(2): 182-9, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24359690

RESUMEN

GABA transporters (GATs) are an essential element of the GABAergic system, which regulate excitability in the central nervous system and are thus used as targets for anticonvulsive therapy. However, in the immature nervous system the functions of the GABAergic system and the expression profile of GATs are distinct from the adult situation, obscuring to predict how different GAT isoforms influence epileptiform activity. Therefore we analyzed the effects of subtype specific GAT inhibitors on repetitive epileptiform discharges using field potential and whole-cell patch-clamp recordings in the CA3 region of hippocampal slices of immature (postnatal days 4-7) rats. These experiments revealed that inhibition of GAT-1 with either tiagabine (30 µM) or NO-711 (10 µM) exhibited only a minor anticonvulsive effect on repetitive epileptiform discharges. Blockade of GAT-2/3 with SNAP-5114 (40 µM) had no anticonvulsive effect, but significantly prolonged the decay of spontaneous GABAergic postsynaptic currents. In contrast, the combined application of 10 µM NO-711 and 40 µM SNAP-5114 blocked epileptiform activity in 33% of all slices and reduced the occurrence of epileptiform discharges by 54% in the remaining slices. In addition, the input resistance decreased by 10.5 ± 1.0% under this condition. These results indicate that both GAT-1 and GAT-2/3 are functional in the immature hippocampus and that only the combined inhibition of GAT 1-3 is sufficient to promote a considerable anticonvulsive effect. We conclude from these results that both GAT-1 and GAT-2/3 act synergistically to regulate the excitability in the immature hippocampus.


Asunto(s)
4-Aminopiridina/toxicidad , Región CA3 Hipocampal/crecimiento & desarrollo , Región CA3 Hipocampal/fisiopatología , Antagonistas del GABA/farmacología , Proteínas Transportadoras de GABA en la Membrana Plasmática/fisiología , Inhibidores de Recaptación de GABA/farmacología , Inhibición Neural/fisiología , 4-Aminopiridina/administración & dosificación , Potenciales de Acción/efectos de los fármacos , Potenciales de Acción/fisiología , Animales , Animales Recién Nacidos , Región CA3 Hipocampal/efectos de los fármacos , Antagonistas del GABA/uso terapéutico , Proteínas Transportadoras de GABA en la Membrana Plasmática/metabolismo , Masculino , Inhibición Neural/efectos de los fármacos , Técnicas de Cultivo de Órganos , Ratas , Ratas Wistar , Convulsiones/tratamiento farmacológico , Convulsiones/fisiopatología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA